英賽德藥學INCY
那斯達克 · USD
74.84
-0.05
(-0.07%)
盤中 08/02 01:06 (UTC+8)
08/02 01:06 (UTC+8)
英賽德藥學INCY
74.84
-0.05
(-0.07%)
財務數據
損益表
- 8.09
- 9.55
- 9.19
- 10.13
- 8.81
- 10.44
- 11.38
- 11.79
- 10.53
- 12.16
- -12.74
- 18.05
- -3.73
- 10.26
- -13.07
- 18.49
- 9.02
- 3.59
- -10.67
- 15.45
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 1,215,529 | 1,052,898 | 1,178,698 | 1,137,871 | 1,043,759 | 880,889 | 1,013,341 | 919,025 | 954,610 | 808,673 |
營業成本 | 78,800 | 73,188 | 88,485 | 85,993 | 76,634 | 60,956 | 69,751 | 60,091 | 68,326 | 56,822 |
營業毛利 | 1,136,729 | 979,710 | 1,090,213 | 1,051,878 | 967,125 | 819,933 | 943,590 | 858,934 | 886,284 | 751,851 |
營業費用 | 825,917 | - | 788,700 | 905,793 | 1,445,255 | 728,035 | 756,320 | 644,229 | 692,504 | 727,081 |
研發費用 | 494,917 | 437,279 | 466,034 | 573,174 | 1,138,380 | 429,260 | 444,494 | 375,709 | 400,750 | 406,641 |
推銷及管理費用 | 331,000 | 337,263 | 322,666 | 332,619 | 306,875 | 298,775 | 311,826 | 268,520 | 291,754 | 320,440 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 310,812 | 205,168 | 301,513 | 146,085 | -478,130 | 91,898 | 187,270 | 214,705 | 193,780 | 24,770 |
其他收入及費用 | - | 31,025 | 22,811 | 24,195 | 49,769 | 144,691 | 94,329 | 56,210 | 84,479 | 27,555 |
利息費用 | 594 | 660 | 419 | 774 | 657 | 430 | 804 | 623 | 655 | 469 |
稅前純益 | 558,012 | 234,190 | 313,724 | 156,524 | -389,777 | 236,159 | 270,956 | 233,799 | 277,604 | 51,856 |
所得稅 | 153,013 | 75,987 | 112,512 | 50,068 | 54,824 | 66,611 | 69,877 | 62,530 | 74,056 | 30,153 |
稅後純益 | 404,999 | 158,203 | 201,212 | 106,456 | -444,601 | 169,548 | 201,079 | 171,269 | 203,548 | 21,703 |
基本每股稅後盈餘(元) | 2.09 | 0.82 | 1.04 | 0.55 | -2.04 | 0.76 | 0.90 | 0.76 | 0.91 | 0.10 |
稀釋每股稅後盈餘(元) | 2.04 | 0.80 | 0.95 | 0.44 | -1.99 | 0.75 | 0.89 | 0.76 | 0.90 | 0.10 |
基本平均股數(千股) | 193995.00 | 193712.00 | 193152.00 | 192629.00 | 218175.00 | 224484.00 | 224226.00 | 224078.00 | 223248.00 | 222960.00 |
稀釋平均股數(千股) | 198744.00 | 198197.00 | 197423.00 | 195838.00 | 218175.00 | 227219.00 | 226125.00 | 226167.00 | 225649.00 | 225589.00 |
還原基本每股稅後盈餘(元) | 2.09 | 0.82 | 1.04 | 0.55 | -2.04 | 0.76 | 0.90 | 0.76 | 0.91 | 0.10 |
還原稀釋每股稅後盈餘(元) | 2.04 | 0.80 | 0.95 | 0.44 | -1.99 | 0.75 | 0.89 | 0.76 | 0.90 | 0.10 |
還原基本平均股數(千股) | 193,995 | 193,712 | 193,152 | 192,629 | 218,175 | 224,484 | 224,226 | 224,078 | 223,248 | 222,960 |
還原稀釋平均股數(千股) | 198,744 | 198,197 | 197,423 | 195,838 | 218,175 | 227,219 | 226,125 | 226,167 | 225,649 | 225,589 |
EBITDA(千元) | 581,525 | 257,212 | 336,876 | 179,818 | -367,072 | 258,536 | 293,522 | 255,812 | 298,556 | 71,536 |